跳至主要内容
临床试验/NCT00134420
NCT00134420已完成3 期

Growth Hormone Trial for Children With 18q- and Abnormal Growth

The University of Texas Health Science Center at San Antonio1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2001年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
20
试验地点
1
主要终点
growth rates 12-15 months after treatment begins

研究概览

简要总结

We, the investigators at the University of Texas Health Science Center at San Antonio, want to learn if height and IQ (intelligence quotient) scores are improved by growth hormone (GH) treatment in children with chromosome 18 deletions and abnormal growth. Data from a previous study showed that growth hormone improved height in all children with 18q- and growth hormone deficiency. In addition, most of the study participants on growth hormone treatment showed an increase in IQ scores.

详细描述

HYPOTHESIS:

Our hypothesis with reference to children with 18q deletions who have abnormal growth are:

  • growth hormone will improve growth; and
  • growth hormone will improve performance IQ (pIQ).

Therefore, our specific aims are to evaluate the impact of GH treatment on:

  • linear growth in children with 18q deletions who have abnormal growth but who are not classically growth hormone deficient; and
  • pIQ in children with 18q deletions who have abnormal growth

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of chromosome 18 deletion (cytogenetics report)
  • Children with abnormal growth but who are not classically growth hormone deficient

排除标准

  • Children previously on growth hormone therapy

研究组 & 干预措施

Growth Hormone Treatment

Active Comparator

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done 1st for eligibility and this group received GH (growth hormone) (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)immediately after randomization

干预措施: Nutropin AQ (Drug)

Growth Hormone Treatment

Active Comparator

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done 1st for eligibility and this group received GH (growth hormone) (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)immediately after randomization

干预措施: Arginine and Clonidine Stimulation Testing (Procedure)

Growth Hormone Treatment

Active Comparator

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done 1st for eligibility and this group received GH (growth hormone) (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)immediately after randomization

干预措施: Growth Factors Laboratory Testing (Procedure)

Growth Hormone Treatment

Active Comparator

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done 1st for eligibility and this group received GH (growth hormone) (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)immediately after randomization

干预措施: Neuropsychological Testing (Procedure)

GH treatment delayed by one year

Other

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done first for eligibility and this group received growth hormone (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)after one year of observation

干预措施: Arginine and Clonidine Stimulation Testing (Procedure)

GH treatment delayed by one year

Other

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done first for eligibility and this group received growth hormone (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)after one year of observation

干预措施: Growth Factors Laboratory Testing (Procedure)

GH treatment delayed by one year

Other

Arginine and Clonidine Stimulation Testing, Growth Factors Laboratory Testing, and Neuropsychological Testing was done first for eligibility and this group received growth hormone (Nutropin AQ) 0.3 mgs per kg per week (standard dosing for GH)after one year of observation

干预措施: Neuropsychological Testing (Procedure)

结局指标

主要结局

growth rates 12-15 months after treatment begins

次要结局

  • performance IQ scores 12-15 months after treatment begins

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验